Neurogenic Bladder Dysfunction
12
3
5
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
16.7%
2 terminated out of 12 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Functional and Structural Changes in the Central Nervous System Following Spinal Cord Injury
Non-invasive Spinal Cord Stimulation for Recovery of Autonomic Function After Spinal Cord Injury
Stimulation of Acupuncture Points in Female Patients With Multiple Sclerosis and Neurogenic Bladder Dysfunction
Bladder and TranscUtaneous Tibial Nerve Stimulation for nEurogenic Lower Urinary Tract Dysfunction
RElax & feeL at EASE (RELEASE)
Multiple Sclerosis and Overactive Bladder Treatment
Dorsal Genital Nerve Stimulation for Bladder Management After SCI
Use of Point-of-care Neuro-sacral Electrophysiology Following Spinal Cord Injury
Chronic Electrical Stimulation to Reduce Bladder Hyperreflexia
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis
Transcutaneous Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction
Health-related Quality of Life of Patients With Neurogenic Bladder